Board of Advisors Member
Steven is a member of Improvita’s Board of Advisors. He has over 25 years experience in development and commercialization of medical devices and therapeutics in a variety of environments including industry, start-up, applied research, and academic settings. Steve is currently CEO and co-founder of FloraSeq LLC, a company that is in early stage clinical trials with a microbiota-based drug for treating gastrointestinal diseases. Previously, he was Sr. Director and managed a clinical diagnostic business segment for Hologic Gen-Probe with responsibilities for R&D, marketing, regulatory and business strategy. He led the development and commercialization of seven FDA cleared IVD assays and launched an automated instrument program. Prior to Hologic/Gen-Probe, Steve was CSO and VP of Business Development at clinical diagnostics company Prodesse where he played a significant role in the company’s acquisition by Gen-Probe for $72M. Steve started his career in applied research at Lawrence Livermore National Laboratory where he was Scientist and Group Leader responsible for advancement and deployment of technologies in the areas of clinical medicine and national security. Throughout his career in healthcare he gained extensive experience in developing and commercializing devices and therapeutics, IP/licensing, regulatory, quality systems, marketing, and business strategy. He is also active in mentoring and supporting the start-up community in Wisconsin. Steve obtained his BS degree in Electrical Engineering from Marquette University and his MS and PhD degrees in Biomedical Engineering from Northwestern University.